EDITORIAL
Published on 05 Mar 2018
Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?
doi 10.3389/fimmu.2018.00442
- 2,754 views
- 2 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Is the Recent Burst of Therapeutic Anti-Tumor Antibodies the Tip of an Iceberg?
Is the Recent Burst of Therapeutic Anti-Tumor Antibodies the Tip of an Iceberg?
74k
Total Downloads
364k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 19 Feb 2018
Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment
doi 10.3389/fimmu.2018.00273
- 15,304 views
- 69 citations
ORIGINAL RESEARCH
Published on 29 Jan 2018
92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts
doi 10.3389/fimmu.2018.00077
- 4,897 views
- 18 citations
REVIEW
Published on 17 Jan 2018
Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
doi 10.3389/fimmu.2017.01936
- 14,673 views
- 48 citations
REVIEW
Published on 10 Jan 2018
Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
doi 10.3389/fimmu.2017.01911
- 20,968 views
- 96 citations
REVIEW
Published on 04 Jan 2018
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
doi 10.3389/fimmu.2017.01751
- 26,166 views
- 125 citations
REVIEW
Published on 21 Dec 2017
New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
doi 10.3389/fimmu.2017.01804
- 20,527 views
- 58 citations
ORIGINAL RESEARCH
Published on 11 Dec 2017
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8+ Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy
doi 10.3389/fimmu.2017.01653
- 4,626 views
- 49 citations
REVIEW
Published on 04 Dec 2017
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
doi 10.3389/fimmu.2017.01597
- 34,941 views
- 242 citations
REVIEW
Published on 22 Nov 2017
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
doi 10.3389/fimmu.2017.01603
- 130,550 views
- 426 citations
REVIEW
Published on 13 Nov 2017
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
doi 10.3389/fimmu.2017.01544
- 12,889 views
- 73 citations
REVIEW
Published on 09 Nov 2017
Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?
doi 10.3389/fimmu.2017.01509
- 4,432 views
- 18 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 364kTopic views
- 286kArticle views
- 74kArticle downloads